蛋白质基因分析揭示了MDA-MB-231细胞中塞拉基内林林A诱导的细胞循环阻断
Jing Wen1, Shuai-Cong Ni2,3,4, Xiao-Lin-Mo Ma-Hai2,3,4
1School of Pharmacy, Sichuan College of Traditional Chinese Medicine, Mianyang, China.
Bioscience, biotechnology, and biochemistry
|September 29, 2025
概括
塞拉基内林 A 通过向 PTP1B 抑制了三阴性乳腺癌细胞的生长. 这种作用会破坏关键的信号通路,导致细胞循环停止和减少MDA-MB-231细胞的增殖.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 由于有限的向疗法,三阴性乳腺癌 (TNBC) 仍然是一个重大的健康挑战.
- 塞拉吉内拉tamariscina衍生物已经显示出潜在的抗癌性质.
- 了解这些化合物的分子机制对于治疗开发至关重要.
研究的目的:
- 为了研究Selaginellin A (Sela A) 对MDA-MB-231三阴性乳腺癌细胞的抗癌作用.
- 为了阐明Sela A.所针对的分子通路.
- 确定TNBC治疗的潜在治疗点.
主要方法:
- 在Sela A处理后进行蛋白质基因分析,以识别差异表达蛋白质.
- 生物信息丰富分析以确定受影响的细胞通路.
- 酶抑制试验用于评估PTP1B抑制活性.
- 西方涂抹用于分析关键蛋白质信号通路 (mTOR,IRS1,Akt,p70S6K).
主要成果:
- 塞拉A治疗导致参与DNA修复,复制和细胞周期进展的蛋白质的显著下调.
- 塞拉A被确定为一种蛋白铁酸酶1B (PTP1B) 抑制剂,其IC50为7.4微米.
- 塞拉A抑制PTP1B激活了mTOR,这反过来导致IRS1降解并抑制了Akt信号传递,最终导致G1阶段细胞周期停止.
结论:
- 塞拉基内林A对MDA-MB-231 TNBC细胞表现出抗增殖作用.
- 该机制涉及PTP1B抑制,导致mTOR激活和随后的IRS1/Akt路径失调.
- 塞拉A代表了TNBC的潜在治疗候选者,需要进一步调查.
更多相关视频
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules
38.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Molecular Factors Affecting Cell Division
3.8K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.8K
Positive Regulator Molecules
6.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K


